Ambiya Vikas, Das Taraprasad, Sharma Savitri, Chhablani Jay, Dave Vivek, Jalali Subhadra, Narayanan Raja, Joseph Joveeta
Srimati Kanuri Santhamma Retina Vitreous Center, Kallam Anji Reddy Campus, LV Prasad Eye Institute, Hyderabad, India.
LV Prasad Eye Institute, Road No. 2, LV Prasad Marg, Banjara Hills, Hyderabad, 500034, India.
J Ophthalmic Inflamm Infect. 2016 Dec;6(1):45. doi: 10.1186/s12348-016-0113-0. Epub 2016 Nov 24.
The purpose of the study is to compare the clinico-microbiological profile and treatment outcome of in-house vs referred cases of post cataract surgery endophthalmitis in a tertiary eye care facility in South India.
The clinical records of 50 culture-positive cases each of in-house (group A) and referred (group B) post cataract surgery endophthalmitis were analyzed. The management protocol was similar in both groups.
The time to report to the institute was longer in group B (group B 13.63 [±11.67; 95% CI, 9.95-17.31] days; group A 6.83 [±7.61; 95% CI, 4.57-9.09] days; P = 0.002). The average inflammatory scores in presentation were comparable (group A 17.85 ± 5.83; group B 18.18 ± 7.35; P = 0.243). The final visual outcome was clinically superior in group A (≥20/200-group A 60.42% and group B 44%, P = 0.11; ≤20/400-group A 37.5% and group B 52%, P = 0.62), but statistically not significant. There were more gram-positive organisms in group A (62% vs 38%; P = 0.027) and more gram-negative organisms in group B (52% vs 24%; P = 0.007). Gram-positive bacteria were mostly sensitive to vancomycin (95.24% to 96.67%), but gram-negative bacteria were partly sensitive to ceftazidime (58.33% to 64%).
One could suspect gram-negative infection more often in the referred cases of endophthalmitis. While vancomycin could continue to be the antibiotic of choice in gram-positive bacteria, specific antibiotic following due sensitivity for gram-negative bacteria should replace the empiric use of ceftazidime.
本研究旨在比较印度南部一家三级眼科护理机构中白内障手术后眼内炎的院内病例与转诊病例的临床微生物学特征及治疗结果。
分析了50例白内障手术后眼内炎的院内病例(A组)和转诊病例(B组)的临床记录,每组各50例培养阳性病例。两组的管理方案相似。
B组向研究所报告的时间更长(B组13.63 [±11.67;95%可信区间,9.95 - 17.31]天;A组6.83 [±7.61;95%可信区间,4.57 - 9.09]天;P = 0.002)。就诊时的平均炎症评分相当(A组17.85 ± 5.83;B组18.18 ± 7.35;P = 0.243)。A组的最终视力结果在临床上更优(≥20/200 - A组60.42%,B组44%,P = 0.11;≤20/400 - A组37.5%,B组52%,P = 0.62),但差异无统计学意义。A组革兰氏阳性菌更多(62%对38%;P = 0.027),B组革兰氏阴性菌更多(52%对24%;P = 0.007)。革兰氏阳性菌大多对万古霉素敏感(95.24%至96.67%),但革兰氏阴性菌对头孢他啶部分敏感(58.33%至64%)。
在转诊的眼内炎病例中,更常怀疑革兰氏阴性感染。虽然万古霉素可继续作为革兰氏阳性菌的首选抗生素,但对革兰氏阴性菌进行药敏试验后使用特定抗生素应取代经验性使用头孢他啶。